JP2015502340A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015502340A5 JP2015502340A5 JP2014539044A JP2014539044A JP2015502340A5 JP 2015502340 A5 JP2015502340 A5 JP 2015502340A5 JP 2014539044 A JP2014539044 A JP 2014539044A JP 2014539044 A JP2014539044 A JP 2014539044A JP 2015502340 A5 JP2015502340 A5 JP 2015502340A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- antibody
- variable region
- chain variable
- subject
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161552337P | 2011-10-27 | 2011-10-27 | |
| US61/552,337 | 2011-10-27 | ||
| PCT/US2012/062124 WO2013063395A1 (en) | 2011-10-27 | 2012-10-26 | Humanized antibodies to inkt |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2015502340A JP2015502340A (ja) | 2015-01-22 |
| JP2015502340A5 true JP2015502340A5 (https=) | 2015-12-17 |
Family
ID=48168549
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014539044A Pending JP2015502340A (ja) | 2011-10-27 | 2012-10-26 | ｉＮＫＴに対するヒト化抗体 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US9932402B2 (https=) |
| EP (1) | EP2755688A4 (https=) |
| JP (1) | JP2015502340A (https=) |
| KR (1) | KR20140093964A (https=) |
| CN (1) | CN103945867B (https=) |
| AU (1) | AU2012328588C1 (https=) |
| BR (1) | BR112014009962A2 (https=) |
| CA (1) | CA2853719A1 (https=) |
| HK (2) | HK1199837A1 (https=) |
| IL (1) | IL232017A0 (https=) |
| RU (1) | RU2014120694A (https=) |
| SG (1) | SG11201401319XA (https=) |
| WO (1) | WO2013063395A1 (https=) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2014244444A1 (en) * | 2013-03-14 | 2015-09-24 | Amgen Inc. | CHRDL-1 antigen binding proteins and methods of treatment |
| WO2015069697A2 (en) * | 2013-11-05 | 2015-05-14 | Nkt Therapeutics Inc. | Combination therapy |
| SG11201605580RA (en) | 2014-01-10 | 2016-10-28 | Anaptysbio Inc | Antibodies directed against interleukin-33 (il-33) |
| WO2015121393A1 (en) * | 2014-02-14 | 2015-08-20 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods and pharmaceutical compositions for the treatment of acute exacerbations of chronic obstructive pulmonary disease |
| TWI664190B (zh) * | 2014-06-27 | 2019-07-01 | 美商Ｃ２Ｎ醫療診斷有限責任公司 | 人類化抗－ｔａｕ抗體 |
| WO2016013672A1 (ja) * | 2014-07-25 | 2016-01-28 | 国立研究開発法人理化学研究所 | メモリーインバリアントｎｋｔ細胞マーカー |
| WO2016018850A1 (en) * | 2014-07-28 | 2016-02-04 | Nkt Therapeutics Inc. | Combination therapy with il-12 |
| US11933786B2 (en) | 2015-03-30 | 2024-03-19 | Stcube, Inc. | Antibodies specific to glycosylated PD-L1 and methods of use thereof |
| KR102809728B1 (ko) | 2015-12-02 | 2025-05-21 | 주식회사 에스티큐브 | 글리코실화된 pd-1에 대해 특이적인 항체 및 이의 사용 방법 |
| KR20180130541A (ko) | 2016-03-29 | 2018-12-07 | 주식회사 에스티큐브앤컴퍼니 | 글리코실화된 면역체크포인트 단백질에 특이적으로 결합하는 항체를 선택하는 방법 |
| JP6967528B2 (ja) | 2016-04-04 | 2021-11-17 | バイオベラティブ ユーエスエー インコーポレイテッド | 抗補体Ｂｂ因子抗体及びその使用 |
| EP3487883B1 (en) | 2016-07-20 | 2023-01-04 | Stcube, Inc. | Methods of cancer treatment and therapy using a combination of antibodies that bind glycosylated pd-l1 |
| WO2018052818A1 (en) * | 2016-09-16 | 2018-03-22 | Henlix, Inc. | Anti-pd-1 antibodies |
| WO2020156335A1 (zh) * | 2019-01-29 | 2020-08-06 | 上海交通大学 | 一种嵌合抗原受体及其应用 |
| KR20230004686A (ko) * | 2020-04-20 | 2023-01-06 | 젠자임 코포레이션 | 인간화 항-보체 인자 Bb 항체 및 그의 용도 |
| CN115666586A (zh) * | 2020-04-23 | 2023-01-31 | 加州大学评议会 | 通过激活iNKT细胞清除衰老细胞 |
| CN117222414A (zh) | 2021-03-01 | 2023-12-12 | 脱落性治疗公司 | 用于激活恒定自然杀伤t-细胞的化合物和用于消除炎性衰老细胞的方法 |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7119248B1 (en) | 1994-04-12 | 2006-10-10 | Miltenyi Biotec Gmbh | Antibodies against epitopes with homology to self antigens, methods of preparation and applications thereof |
| WO1997016203A1 (en) | 1995-11-01 | 1997-05-09 | Genetics Institute, Inc. | Methods for administration of il-12 |
| WO1999034209A1 (en) | 1997-12-31 | 1999-07-08 | The Brigham And Women's Hospital, Inc. | DIAGNOSTIC AND THERAPEUTIC METHODS BASED UPON Vα24JαQ T CELLS |
| DK2336187T3 (en) * | 2000-06-19 | 2016-08-22 | Beth Israel Deaconess Medical Ct Inc | Compositions and Methods of monoclonal and polyclonal antibodies which are specific for T-cell subpopulations |
| US7101977B2 (en) * | 2001-07-17 | 2006-09-05 | Research Development Foundation | Therapeutic agents comprising pro-apoptotic proteins |
| HK1079882B (en) | 2002-06-14 | 2011-11-25 | The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Methods of treating and preventing colitis involving il-13 and nk-t cells |
| US9809654B2 (en) * | 2002-09-27 | 2017-11-07 | Vaccinex, Inc. | Targeted CD1d molecules |
| CA2577009C (en) | 2004-08-27 | 2017-05-02 | Albert Einstein College Of Medicine, Inc. | Ceramide derivatives as modulators of immunity and autoimmunity |
| CA2584971C (en) * | 2004-11-02 | 2013-08-06 | The Board Of Trustees Of The Leland Stanford Junior University | Methods for inhibition of nkt cells |
| PE20071101A1 (es) | 2005-08-31 | 2007-12-21 | Amgen Inc | Polipeptidos y anticuerpos |
| WO2008140487A2 (en) * | 2006-11-14 | 2008-11-20 | Elusys Therapeutics, Inc. | Improved staphylococcal protein a mono- and bispecific antibodies and methods of their use |
| US20100035843A1 (en) | 2007-02-12 | 2010-02-11 | The General Hospital Corporation | Methods for attenuating allergen-induced airway hyperreactivity using cd1d dependent antagonists |
| US8012484B2 (en) * | 2007-04-12 | 2011-09-06 | University Of Virginia Patent Foundation | Method of treating ischemia reperfusion injury by inhibiting NKT cell activity |
| US20090028849A1 (en) | 2007-07-24 | 2009-01-29 | O'brien Rebecca L | Agents and methods for inhibition of airway hyperresponsiveness |
| US20110300154A1 (en) * | 2007-08-21 | 2011-12-08 | Children's Medical Center Corporation | Treatment of airway hyperreactivity |
| EP2222700A2 (en) | 2007-11-27 | 2010-09-01 | Medtronic, Inc. | Humanized anti-amyloid beta antibodies |
| GB0902916D0 (en) | 2009-02-20 | 2009-04-08 | Fusion Antibodies Ltd | Antibody therapy |
| WO2011112889A2 (en) | 2010-03-12 | 2011-09-15 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | β-MANNOSYLCERAMIDE AND STIMULATION OF NKT CELL ANTI-TUMOR IMMUNITY |
| EP2575824A4 (en) | 2010-05-24 | 2014-02-19 | Childrens Medical Center | METHOD FOR THE TREATMENT AND PREVENTION OF INFLAMMATORY DISEASES |
| US9365496B2 (en) | 2011-11-30 | 2016-06-14 | Ludwig Institute For Cancer Research | iNKT cell modulators and methods of using the same |
| WO2015069697A2 (en) | 2013-11-05 | 2015-05-14 | Nkt Therapeutics Inc. | Combination therapy |
| WO2016018850A1 (en) | 2014-07-28 | 2016-02-04 | Nkt Therapeutics Inc. | Combination therapy with il-12 |
-
2012
- 2012-10-26 BR BR112014009962A patent/BR112014009962A2/pt not_active IP Right Cessation
- 2012-10-26 US US13/661,386 patent/US9932402B2/en not_active Expired - Fee Related
- 2012-10-26 RU RU2014120694/10A patent/RU2014120694A/ru not_active Application Discontinuation
- 2012-10-26 KR KR1020147014125A patent/KR20140093964A/ko not_active Abandoned
- 2012-10-26 HK HK15100381.0A patent/HK1199837A1/xx unknown
- 2012-10-26 HK HK14113013.0A patent/HK1199405A1/xx unknown
- 2012-10-26 CN CN201280053174.3A patent/CN103945867B/zh not_active Expired - Fee Related
- 2012-10-26 SG SG11201401319XA patent/SG11201401319XA/en unknown
- 2012-10-26 WO PCT/US2012/062124 patent/WO2013063395A1/en not_active Ceased
- 2012-10-26 EP EP12843689.6A patent/EP2755688A4/en not_active Withdrawn
- 2012-10-26 AU AU2012328588A patent/AU2012328588C1/en not_active Ceased
- 2012-10-26 JP JP2014539044A patent/JP2015502340A/ja active Pending
- 2012-10-26 CA CA2853719A patent/CA2853719A1/en not_active Abandoned
-
2014
- 2014-04-08 IL IL232017A patent/IL232017A0/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2015502340A5 (https=) | ||
| RU2014120694A (ru) | ГУМАНИЗИРОВАННЫЕ АНТИТЕЛА К iNKT | |
| CN113710229B (zh) | 用与抗炎剂连接的ecm亲和肽治疗炎症性和自身免疫性病症的方法和组合物 | |
| IL274595B2 (en) | Antibodies specific to beta-tgf | |
| JP2014526898A5 (https=) | ||
| JP2013538057A5 (https=) | ||
| JP2015535828A5 (https=) | ||
| JP2018512138A5 (https=) | ||
| JP2012525829A5 (https=) | ||
| JP2017504577A5 (https=) | ||
| HRP20230844T1 (hr) | Anti-cd3 antitijela, bispecifične molekule koje vežu antigen koji veže cd3 i cd20, i njihove upotrebe | |
| JP2012501669A5 (https=) | ||
| RU2018112861A (ru) | Стабильные антитела, связывающиеся с несколькими антигенами | |
| JP2015511962A5 (https=) | ||
| JP2014509510A5 (https=) | ||
| TR201817932T4 (en) | ANTIBODIES THAT BIND STAPHYLOCOCCUS AUREUS ALPHA TOXIN SPECIFICALLY AND METHODS OF USE | |
| RU2015136078A (ru) | Антитело против с5 и способ предупреждения и лечения обусловленных комплементом заболеваний | |
| JP2012254092A5 (https=) | ||
| JP2018515474A5 (https=) | ||
| JP2017505125A5 (https=) | ||
| RU2016100892A (ru) | Антитела против tweakr и их применение | |
| JP2018510617A5 (https=) | ||
| JP2018502060A5 (https=) | ||
| JP2017531427A5 (https=) | ||
| JP2015514110A5 (https=) |